Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia

Medical Hypotheses

Volumn 57, Issue 2, 2001, Pages 175-179

  Yu, P H ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMYLOID BETA PROTEIN; FORMALDEHYDE; HYDROGEN PEROXIDE; METHYLAMINE; SEMICARBAZIDE;

ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; DEAMINATION; DISEASE ASSOCIATION; INFLAMMATION; MULTIINFARCT DEMENTIA; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; REVIEW; RISK FACTOR; SENILE PLAQUE; SMOOTH MUSCLE FIBER MEMBRANE; VASCULAR AMYLOIDOSIS;

EID: 0034913872     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2001.1329     Document Type: Article

References (52)

1. Alzheimer's disease
2. The pathogenesis of senile plaques
3. The alpha-helical to beta strand transition in the ammo-terminal fragment of the amyloid beta-peptide amyloid formation
4. Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide
5. Cerebrovascular pathology in Alzheimer's disease
6. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease
7. Microangiopathy, the vascular basement membrane and Alzheimer's disease: A review
8. Overlap between pathology of Alzheimer disease and vascular dementia
9. Electron microscopy of amyloid fibrils and microvessels
10. Vascular basement membrane components and the lesions of Alzheimer's disease; light and electron microscopic analysis
11. Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly
12. Cerebrovascular pathology in Alzheimer's disease: Cause, effect or epiphenomenon?
13. Arthritis and antiinflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiological studies
14. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease
15. Inflammation and Alzheimer's disease pathogenesis
16. Alzheimer's disease and inflammation: A review of cellular and therapeutic mechanisms
17. Some aspects of the pathophysiology of semicarbazide-sensitive amine oxidase enzymes
18. Amine oxidase in human blood vessels and non-vascular smooth muscle
19. Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sclera
20. Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues: Biochemical and immunohistological characterization
21. The influence of amine metabolizing enzymes on the pharmacology of tyramine in the isolated perfused mesenteric arterial bed of rat
22. Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells
23. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase
24. The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes
25. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta
26. Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase
27. Accumulation of S-D-lactolylglutathione and transient decrease of glutathione level caused by methylglyoxal load in isolated hepatocytes
28. The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery
29. Potential cytotoxic effect of chronic administration of creatine, a nutrition supplement to augment athletic performance
30. Formaldehyde toxicity - New understanding
31. Cancer static action of methylglyoxal
32. Protein cross-linking by the Mailard reaction. Isolation, characterization and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal
33. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells; Possible consequence for diabetes
34. Serum monoamine oxidase in diabetes mellitus and some other internal diseases
35. Increased activity of serum amine oxidase in granuloma annulare, necrobiosis lipoidics and diabetes
36. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin
37. Circulating semicarbazide-sensitive amine oxidase is raised both in type I (insulin-dependent), in type II (non-insulin-dependent) diabetes mellitus and even in childhood type I diabetes at first clinical diagnosis
38. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: Correlation with BMI and serum triglyceride
39. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy
40. Plasma benzylamine oxidase activity in cerebrovascular disease
41. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure
42. Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure
43. Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats
44. Physiological and pathological influences on sheep blood plasma amine oxidase: Effect of pregnancy and experimental alloxan-induced diabetes mellitus
45. Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes
46. Formaldehyde produced endogenously via deamination of methylamine; a potential risk factor for initiation of endothelial injury
47. Endogenous formaldehyde and vulnerability of atherosclerosis: Involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover
48. Cloning of vascular adhesion protein a; Reveals a novel multifunctional adhesion molecule
49. Induction and function of adhesion protein-1 at sites of inflammation
50. Mouse vascular adhesion protein 1 is a sialoglycoprotein with enzymatic activity and is induced in diabetic insulitis
51. Inflammation of the brain in Alzheimer's disease: Implications for therapy